Pulmonx Reports Fourth Quarter and Full Year 2021 Financial

REDWOOD CITY, Calif., Feb. 23, 2022 -- Pulmonx Corporation , a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full... | February 23, 2022

Related Keywords

Japan , United States , France , French , Pulmonx Zephyr , Brian Johnston , Exchange Commission , Gilmartin Group , Securities Exchange , Pulmonx Corporation Nasdaq , Pulmonx Corporation , Globenewswire Inc , Zephyr Valves , Zephyr Valve , Chief Executive , First Quarter , Conference Call , Investor Relations , Securities Act , Securities Exchange Act , Risk Factors , Quarterly Report , Endobronchial Valve , Pulmonary Assessment System , Lung Analysis Platform , Reported Revenue , Constant Currency Revenue , Pulmonx Corporation Stock Exchange , News , Information , Press Release , Redwood , 022 , Pulmonx , Corporation , Lobal , Leader , N , Minimally , Nvasive , Treatments , Or , Young , Oday , Eported , Financial , Results , The , Fourth , Quarter , Nd Lung Us7458481014 ,